EXECUTIVE ENGAGEMENTS
OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
* Login for a full stack data experience
DATE
SEP 2020
TABLES
66
PAGES
162
EDITION
16
PRICE
USD $5600
Is the U.S. Still a Better Global Barometer than China?
SELECT PLAYERS
apceth Biopharma GmbH; Athersys Inc.; AVIVA BioSciences Corporation; BioE Inc.; Bone Therapeutics SA; Cesca Therapeutics Inc.; Cryo-Cell International Inc.; Cytori Therapeutics Inc.; ESI BIO; Gamida Cell Ltd.; Holostem Terapie Avanzate; International Stem Cell Corp.; Kangstem Biotech. Ltd.; Lonza Group Ltd.; Mesoblast Ltd.; Neuralstem Inc.; Nuvasive Inc.; OncoMed Pharmaceuticals Inc.; Osiris Therapeutics Inc.; Promethera Biosciences S.A.N.V; Reliance Life Sciences; ReNeuron Group Plc.; Stemcell Technologies Inc.; Stemedica Cell Technologies Inc.; Stempeutics Research Pvt. Ltd.; Takara Bio USA Inc.; TiGenix NV; U.S Stem Cell Inc.; ViaCord
SEGMENTS
» Product Type (Adult Stem Cells, Other Product Types) » Application (Regenerative Medicine, Drug Discovery & Development)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlassâ„¢ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
INSIDER ACCESS PRIVILEGES
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries |
| Recent Market Activity |
| Select Approved Stem Cell Products |
| Stem Cells Bypass Use of Animal Models in Drug Discovery Programs |
| Trends Related to Stem Cell Clinical Trials |
| Select Stem Cell Pipeline Analysis |
| Current & Future Analysis |
| Stem Cell Research Funding Policies across the World |
| Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC) Research |
| Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical Applications |
| Dental Mesenchymal Stem Cells - Emergence of a Niche Market |
| For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research |
| Unproven Therapies Do Online Rounds as Effective Treatment Options - A Cause of Concern |
| Global Competitor Market Shares |
| Stem Cells Competitor Market Share Scenario Worldwide (in %): 2020 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Athersys, Inc. (USA) |
| Apceth GmbH & Co.KG (Germany) |
| AVIVA BioSciences Corporation (USA) |
| BioE, Inc. (USA) |
| Bone Therapeutics SA (Belgium) |
| Cesca Therapeutics, Inc. (USA) |
| Cryo-Cell International, Inc. (USA) |
| Cytori Therapeutics, Inc. (USA) |
| ESI BIO, a Division of BioTime Inc. (USA) |
| Gamida Cell Ltd. (Israel) |
| Holostem Terapie Avanzate (Italy) |
| International Stem Cell Corporation (USA) |
| Kangstem Biotech., Ltd. (Korea) |
| Lonza Group Ltd (Switzerland) |
| Mesoblast Ltd. (Australia) |
| Neuralstem, Inc. (USA) |
| Nuvasive, Inc. (USA) |
| Osiris Therapeutics, Inc. (USA) |
| OncoMed Pharmaceuticals, Inc (USA) |
| PROMETHERA Biosciences S.A.N.V (Belgium) |
| Reliance Life Sciences (India) |
| ReNeuron Group Plc. (UK) |
| STEMCELL Technologies, Inc. (Canada) |
| Stemedica Cell Technologies, Inc (USA) |
| Stempeutics Research Pvt. Ltd. (India) |
| Takara Bio USA Inc (USA) |
| TiGenix NV (Belgium) |
| U.S Stem Cell, Inc. (USA) |
| ViaCord, LLC (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells |
| Embryonic Stem Cell Gene Nanog Found to Reverse Aging |
| Canadian and Dutch Scientists Finds the “Genetic Switch” to Increase Stem Cell Volume from Cord Blood |
| The Boston Program Pioneers Cell-based Personalized Diabetes Treatment |
| iPSCs Provide Valuable Source for Retinal Transplants and Other Applications |
| Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac Disorders |
| Stem Cell Therapy - An Alternative to Orthopedic Surgery in Younger Patients? |
| Application of Plant Stem Cells in Cosmetic Treatments - Myths Busted |
| Adverse Reactions of Stem Cell-Face Lift Therapy |
| Stem Cell-Breast Enhancement |
| Other Innovations Using Stem Cells |
| New Stem Cell Software & Products |
| 4. GLOBAL MARKET PERSPECTIVE |
| Stem Cells Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Stem Cells Market Share Shift across Key Geographies Worldwide: 2019 VS 2025 |
| Adult Stem Cells (Product Type) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Adult Stem Cells (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025 |
| Other Product Types (Product Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Other Product Types (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025 |
| Regenerative Medicine (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 |
| Regenerative Medicine (Application) Market Share Breakdown by Region/Country: 2019 VS 2025 |
| Drug Discovery & Development (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025 |
| Drug Discovery & Development (Application) Share Breakdown Review by Region/Country: 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Stem Cells Market Share (in %) by Company: 2020 & 2025 |
| United States Stem Cells Market Estimates and Projections in US$ Million by Product Type: 2018 to 2025 |
| United States Stem Cells Market Share Breakdown by Product Type: 2019 VS 2025 |
| United States Stem Cells Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Stem Cells Market Share Breakdown in the United States by Application: 2019 VS 2025 |
| Canada |
| Canadian Stem Cells Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025 |
| Stem Cells Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2019 and 2025 |
| Canadian Stem Cells Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Canadian Stem Cells Market Share Analysis by Application: 2019 VS 2025 |
| Japan |
| Japanese Market for Stem Cells: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025 |
| Japanese Stem Cells Market Share Analysis by Product Type: 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Stem Cells in US$ Million by Application: 2018 to 2025 |
| Stem Cells Market Share Shift in Japan by Application: 2019 VS 2025 |
| China |
| Chinese Stem Cells Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025 |
| Chinese Stem Cells Market by Product Type: Percentage Breakdown of Sales for 2019 and 2025 |
| Chinese Demand for Stem Cells in US$ Million by Application: 2018 to 2025 |
| Chinese Stem Cells Market Share Breakdown by Application: 2019 VS 2025 |
| Europe |
| Market Facts & Figures |
| European Stem Cells Market: Competitor Market Share Scenario (in %) for 2020 & 2025 |
| European Stem Cells Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| European Stem Cells Market Share Shift by Region/Country: 2019 VS 2025 |
| European Stem Cells Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025 |
| European Stem Cells Market Share Breakdown by Product Type: 2019 VS 2025 |
| European Stem Cells Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| European Stem Cells Market Share Analysis by Application: 2019 VS 2025 |
| France |
| Stem Cells Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Stem Cells Market Share Analysis by Product Type: 2019 VS 2025 |
| Stem Cells Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 |
| French Stem Cells Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025 |
| Germany |
| Stem Cells Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2018-2025 |
| German Stem Cells Market Share Breakdown by Product Type: 2019 VS 2025 |
| Stem Cells Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Stem Cells Market Share Distribution in Germany by Application: 2019 VS 2025 |
| Italy |
| Italian Stem Cells Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025 |
| Italian Stem Cells Market by Product Type: Percentage Breakdown of Sales for 2019 and 2025 |
| Italian Demand for Stem Cells in US$ Million by Application: 2018 to 2025 |
| Italian Stem Cells Market Share Breakdown by Application: 2019 VS 2025 |
| United Kingdom |
| United Kingdom Market for Stem Cells: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025 |
| United Kingdom Stem Cells Market Share Analysis by Product Type: 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Stem Cells in US$ Million by Application: 2018 to 2025 |
| Stem Cells Market Share Shift in the United Kingdom by Application: 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Stem Cells Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025 |
| Rest of Europe Stem Cells Market Share Breakdown by Product Type: 2019 VS 2025 |
| Rest of Europe Stem Cells Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Rest of Europe Stem Cells Market Share Analysis by Application: 2019 VS 2025 |
| Asia-Pacific |
| Stem Cells Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Stem Cells Market Share Analysis by Product Type: 2019 VS 2025 |
| Stem Cells Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 |
| Asia-Pacific Stem Cells Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025 |
| Rest of World |
| Rest of World Stem Cells Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025 |
| Stem Cells Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2019 and 2025 |
| Rest of World Stem Cells Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Rest of World Stem Cells Market Share Analysis by Application: 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 66 Click here to request a full table of contents and more details on this project. |
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlassâ„¢ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.